VTN and pancreatic neoplasm: VTN is ubiquitously present in human plasma and the extracellular matrix (42), our findings suggest that its decline in pancreatic cancer tissues is predominantly driven by intrinsic downregulation within malignant cells rather than systemic depletion in peripheral blood.